Literature DB >> 16886055

Misbehaving macrophages in the pathogenesis of psoriasis.

Rachael A Clark1, Thomas S Kupper.   

Abstract

Psoriasis is a chronic inflammatory skin disease unique to humans. In this issue of the JCI, 2 studies of very different mouse models of psoriasis both report that macrophages play a key role in inducing psoriasis-like skin disease. Psoriasis is clearly a polygenic, inherited disease of uncontrolled cutaneous inflammation. The debate that currently rages in the field is whether psoriasis is a disease of autoreactive T cells or whether it reflects an intrinsic defect within the skin--or both. However, these questions have proven difficult to dissect using molecular genetic tools. In the current studies, the authors have used 2 different animal models to address the role of macrophages in disease pathogenesis: Wang et al. use a mouse model in which inflammation is T cell dependent, whereas the model used by Stratis et al. is T cell independent (see the related articles beginning on pages 2105 and 2094, respectively). Strikingly, both groups report an important contribution by macrophages, implying that macrophages can contribute to both epithelial-based and T cell-mediated pathways of inflammation.

Entities:  

Mesh:

Year:  2006        PMID: 16886055      PMCID: PMC1523394          DOI: 10.1172/JCI29441

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  The role of T cells in psoriasis.

Authors:  J C Prinz
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-05       Impact factor: 6.166

3.  Epithelium-lining macrophages in psoriasis.

Authors:  J J van den Oord; C de Wolf-Peeters
Journal:  Br J Dermatol       Date:  1994-05       Impact factor: 9.302

4.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

5.  Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice.

Authors:  M Schön; D Denzer; R C Kubitza; T Ruzicka; M P Schön
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

6.  Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Authors:  E Olsen; M Duvic; A Frankel; Y Kim; A Martin; E Vonderheid; B Jegasothy; G Wood; M Gordon; P Heald; A Oseroff; L Pinter-Brown; G Bowen; T Kuzel; D Fivenson; F Foss; M Glode; A Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; P Bacha; J Nichols
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

Review 7.  Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis.

Authors:  B J Nickoloff
Journal:  J Investig Dermatol Symp Proc       Date:  2000-12

8.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.

Authors:  Manolis Pasparakis; Gilles Courtois; Martin Hafner; Marc Schmidt-Supprian; Arianna Nenci; Atiye Toksoy; Monika Krampert; Matthias Goebeler; Reinhard Gillitzer; Alain Israel; Thomas Krieg; Klaus Rajewsky; Ingo Haase
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

9.  Etanercept as monotherapy in patients with psoriasis.

Authors:  Craig L Leonardi; Jerold L Powers; Robert T Matheson; Bernard S Goffe; Ralph Zitnik; Andrea Wang; Alice B Gottlieb
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

10.  Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

Authors:  Frank O Nestle; Curdin Conrad; Adrian Tun-Kyi; Bernhard Homey; Michael Gombert; Onur Boyman; Günter Burg; Yong-Jun Liu; Michel Gilliet
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

View more
  34 in total

1.  Development of paclitaxel-TyroSpheres for topical skin treatment.

Authors:  Brian E Kilfoyle; Larisa Sheihet; Zheng Zhang; Marissa Laohoo; Joachim Kohn; Bozena B Michniak-Kohn
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

2.  Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns.

Authors:  Vivek Choudhary; Rawipan Uaratanawong; Ravi R Patel; Hirel Patel; Wendi Bao; Bernadette Hartney; Elyssa Cohen; Xunsheng Chen; Qing Zhong; Carlos M Isales; Wendy B Bollag
Journal:  J Invest Dermatol       Date:  2018-10-31       Impact factor: 8.551

3.  Re: misbehaving macrophages in the pathogenesis of psoriasis. Response to Clark and Kupper.

Authors:  Ingo Haase
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 4.  The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.

Authors:  Joshua A Zeichner; April Armstrong
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

5.  Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.

Authors:  Yvonne Baumer; Qimin Ng; Gregory E Sanda; Amit K Dey; Heather L Teague; Alexander V Sorokin; Pradeep K Dagur; Joanna I Silverman; Charlotte L Harrington; Justin A Rodante; Shawn M Rose; Nevin J Varghese; Agastya D Belur; Aditya Goyal; Joel M Gelfand; Danielle A Springer; Christopher Ke Bleck; Crystal L Thomas; Zu-Xi Yu; Mårten Cg Winge; Howard S Kruth; M Peter Marinkovich; Aditya A Joshi; Martin P Playford; Nehal N Mehta
Journal:  JCI Insight       Date:  2018-01-11

6.  Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.

Authors:  Sean M Rowley; Teneema Kuriakose; Lee M Dockery; Thi Tran-Nguyen; Aaron D Gingerich; Lai Wei; Wendy T Watford
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

7.  Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation.

Authors:  H C Pal; J C Chamcheu; V M Adhami; G S Wood; C A Elmets; H Mukhtar; F Afaq
Journal:  Br J Dermatol       Date:  2014-12-23       Impact factor: 9.302

Review 8.  Chemokine receptor antagonists: overcoming developmental hurdles.

Authors:  Richard Horuk
Journal:  Nat Rev Drug Discov       Date:  2008-12-12       Impact factor: 84.694

Review 9.  Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.

Authors:  Zheng Zhang; Pei-Chin Tsai; Tannaz Ramezanli; Bozena B Michniak-Kohn
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-02-05

10.  Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice.

Authors:  Julia Menke; Mei-Yu Hsu; Katelyn T Byrne; Julie A Lucas; Whitney A Rabacal; Byron P Croker; Xiao-Hua Zong; E Richard Stanley; Vicki R Kelley
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.